Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roula Tsonaka

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
EMBO Molecular Medicine|March 22, 2021
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patientsMirko Signorelli, Mitra Ebrahimpoor, Olga Veth, et al.
Acta Ophthalmologica|February 10, 2021
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laserThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYHelena M A Feenstra, Roselie M H Diederen, Martine J C M Lamme, et al.
Circulation Research|May 19, 2022
Sbk2, a Newly Discovered Atrium-Enriched Regulator of Sarcomere IntegrityPim R R van Gorp, Juan Zhang, Jia Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 8, 2026
Evaluation of a serum protein signature as monitoring biomarker for Duchenne Muscular Dystrophy in a long-term clinical trial with corticosteroidsChiara Degan, Rebecca A Tobin, Sharon I de Vries, et al.
Skeletal Muscle|July 14, 2026
Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroidsChiara Degan, Rebecca A Tobin, Sharon I de Vries, et al.
Blood|August 31, 2022
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host diseaseAstrid G S van Halteren, Jessica S Suwandi, Sander Tuit, et al.
The European Respiratory Journal|April 2, 2021
Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box projectEbru Dirikgil, Rick Roos, Geert H Groeneveld, et al.
Plos Neglected Tropical Diseases|December 22, 2022
Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)Pytsje T Hoekstra, Miriam Casacuberta-Partal, Lisette van Lieshout, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
EMBO Molecular Medicine|March 22, 2021
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patientsMirko Signorelli, Mitra Ebrahimpoor, Olga Veth, et al.
Acta Ophthalmologica|February 10, 2021
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laserThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYHelena M A Feenstra, Roselie M H Diederen, Martine J C M Lamme, et al.
Circulation Research|May 19, 2022
Sbk2, a Newly Discovered Atrium-Enriched Regulator of Sarcomere IntegrityPim R R van Gorp, Juan Zhang, Jia Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 8, 2026
Evaluation of a serum protein signature as monitoring biomarker for Duchenne Muscular Dystrophy in a long-term clinical trial with corticosteroidsChiara Degan, Rebecca A Tobin, Sharon I de Vries, et al.
Skeletal Muscle|July 14, 2026
Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroidsChiara Degan, Rebecca A Tobin, Sharon I de Vries, et al.
Blood|August 31, 2022
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host diseaseAstrid G S van Halteren, Jessica S Suwandi, Sander Tuit, et al.
The European Respiratory Journal|April 2, 2021
Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box projectEbru Dirikgil, Rick Roos, Geert H Groeneveld, et al.
Plos Neglected Tropical Diseases|December 22, 2022
Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)Pytsje T Hoekstra, Miriam Casacuberta-Partal, Lisette van Lieshout, et al.
Pageof 9